Claire Deligne
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Fast Generation of F(Ab')2 Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.
Journal: European journal of immunology
Published: November 28, 2025
Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans.
Journal: Frontiers in immunology
Published: October 20, 2025
Exclusive investigation on psoriasis: Keratinocytes and fibroblasts confess through transcriptomics
Journal: Medecine sciences : M/S
Published: July 10, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology.
Journal: European journal of immunology
Published: May 16, 2024
A novelty in the oral administration of medication: An Easter egg-shaped capsule
Journal: Medecine sciences : M/S
Published: November 09, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.
Journal: International journal of molecular sciences
Published: March 31, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 26, 2023
Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Journal: Journal of personalized medicine
Published: February 08, 2022
Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?
Journal: Frontiers in oncology
Published: October 23, 2020
Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes.
Journal: Frontiers in immunology
Published: October 11, 2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy.
Journal: Oncoimmunology
Published: September 14, 2020
Last Updated: 09/26/2026